Strepis Nikolaos, Dollee Dennis, Vrins Donny, Vanneste Kevin, Bogaerts Bert, Carrillo Catherine, Bharat Amrita, Horan Kristy, Sherry Norelle L, Seemann Torsten, Howden Benjamin P, Hiltemann Saskia, Chindelevitch Leonid, Stubbs Andrew P, Hays John P
Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre (Erasmus MC), Rotterdam, The Netherlands.
Department of Pathology and Clinical Bioinformatics, Erasmus University Medical Centre (Erasmus MC), Rotterdam, The Netherlands.
BMC Genomics. 2025 Jan 10;26(1):27. doi: 10.1186/s12864-024-11158-5.
The Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) networks 'Seq4AMR' and 'B2B2B AMR Dx' were established to promote collaboration between microbial whole genome sequencing (WGS) and antimicrobial resistance (AMR) stakeholders. A key topic discussed was the frequent variability in results obtained between different microbial WGS-related AMR gene prediction workflows. Further, comparative benchmarking studies are difficult to perform due to differences in AMR gene prediction accuracy and a lack of agreement in the naming of AMR genes (semantic conformity) for the results obtained. To illustrate this problem, and as a capacity-building exercise to encourage stakeholder involvement, a comparative Galaxy-based BenchAMRking platform was developed and validated using datasets from bacterial species with PCR-verified AMR gene presence or absence information from abritAMR.
The Galaxy-based BenchAMRking platform ( https://erasmusmc-bioinformatics.github.io/benchAMRking/ ) specifically focusses on the steps involved in identifying AMR genes from raw reads and sequence assemblies. The platform currently comprises four well-characterised and published workflows that have previously been used to identify AMR genes using WGS data from several different bacterial species. These four workflows, which include the ISO certified abritAMR workflow, make use of different computational tools (or tool versions), and interrogate different AMR gene sequence databases. By utilising their own data, users can investigate potential AMR gene-calling problems associated with their own in silico workflows/protocols, with a potential use case outlined in this publication.
BenchAMRking is a Galaxy-based comparison platform where users can access, visualise, and explore some of the major discrepancies associated with AMR gene prediction from microbial WGS data.
抗菌药物耐药性联合规划倡议(JPIAMR)的“Seq4AMR”和“B2B2B AMR Dx”网络旨在促进微生物全基因组测序(WGS)与抗菌药物耐药性(AMR)利益相关者之间的合作。讨论的一个关键主题是不同微生物WGS相关AMR基因预测工作流程之间结果的频繁变异性。此外,由于AMR基因预测准确性的差异以及所获得结果的AMR基因命名缺乏一致性(语义一致性),比较基准研究难以开展。为说明这一问题,并作为鼓励利益相关者参与的能力建设活动,开发了一个基于Galaxy的比较BenchAMRking平台,并使用来自具有经PCR验证的AMR基因存在或不存在信息的细菌物种的数据集进行了验证。
BenchAMRking是一个基于Galaxy的比较平台,用户可以在该平台上访问、可视化并探索与微生物WGS数据中的AMR基因预测相关的一些主要差异。